Methyl 2-(3,5-bis(difluoromethyl)-1H-pyrazol-1-yl)acetate

Catalog No.: 
ACBRIZ057
CAS No.: 
1260379-26-7
Molecular Formula: 
C8H8F4N2O2
Molecular Weight: 
240.16
Methyl 2-(3,5-bis(difluoromethyl)-1H-pyrazol-1-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$211.00InquiryInquiry
100mg97%$303.00InquiryInquiry
250mg97%$425.00InquiryInquiry
1g97%$848.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(3,5-bis(difluoromethyl)-1H-pyrazol-1-yl)acetate
IUPAC Namemethyl 2-(3,5-bis(difluoromethyl)-1H-pyrazol-1-yl)acetate
Molecular FormulaC8H8F4N2O2
Molecular Weight240.16
SMILESO=C(OC)CN1N=C(C(F)F)C=C1C(F)F
InChI KeyBUIGGBLUFZPLKT-UHFFFAOYSA-N
Synonymmethyl [3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetate;1H-Pyrazole-1-acetic acid, 3,5-bis(difluoromethyl)-, methyl ester
CAS No.1260379-26-7

Synthetic Route by SureRoute

1. ACBRIZ057 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJIUN084 route compound structure diagram
    ACJIUN08477614-79-0In Stock
  4. Then
  5. ACBRIZ057 route product structure diagram
    ACBRIZ0571260379-26-7
Inquiry

2. ACBRIZ057 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYBJ457 route compound structure diagram
    ACAYBJ45739753-78-1In Stock
  2. Plus
  3. ACLGRD815 route compound structure diagram
    ACLGRD81570086-62-3In Stock
  4. Then
  5. ACBRIZ057 route product structure diagram
    ACBRIZ0571260379-26-7
Inquiry

3. ACBRIZ057 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJIUN084 route compound structure diagram
    ACJIUN08477614-79-0In Stock
  4. Then
  5. ACBRIZ057 route product structure diagram
    ACBRIZ0571260379-26-7
Inquiry

Comments (0)